FDA.reportPublic FDA data

Virus Nosode

Product NDC
63083-4003
11-digit product format
630834003
Labeler code
63083
Product ID
63083-4003_24c08841-8cc8-48eb-9a7e-fb9cbbd3791b
Type
HUMAN OTC DRUG
Nonproprietary name
Virus Nosode
Dosage form
LIQUID
Route
ORAL
Labeler
Professional Complementary Health Formulas
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
1984-08-15
Substance
BACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN; COXSACKIEVIRUS A21; DALEA FOLIOLOSA WHOLE; DRABA VERNA WHOLE; HAEMOPHILUS INFLUENZAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN; POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED); VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN
Active strength
30; 30; 30; 30; 30; 30; 30; 30; 30; 30 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
Pharmacologic classes
Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Poliovirus Vaccine [EPC], Live Vaccinia Virus Vaccine [EPC], Poliovirus Vaccines [CS], Smallpox Vaccine [CS], Vaccines, Inactivated [CS], Vaccines, Live, Unattenuated [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Virus Nosode
Brand name suffix
4003
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN30 [hp_X]/59mL
COXSACKIEVIRUS A2130 [hp_X]/59mL
DALEA FOLIOLOSA WHOLE30 [hp_X]/59mL
DRABA VERNA WHOLE30 [hp_X]/59mL
HAEMOPHILUS INFLUENZAE30 [hp_X]/59mL
HUMAN HERPESVIRUS 430 [hp_X]/59mL
HUMAN HERPESVIRUS 530 [hp_X]/59mL
HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN30 [hp_X]/59mL
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)30 [hp_X]/59mL
VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN30 [hp_X]/59mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii8VJE55B0VG, 4B57CWT710, R2ZFR12IQ9, 11I0GD34ZJ, K738E2MB3I, 2A26YW7PNX, 7COI029E6K, 33T61IWL27, 0LVY784C09, 4SV59689SK

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63083-4003-22026-01-08C16284748780-11030e365-467e-111a-e063-dadaa90a10e2N3
63083-4003-22026-01-08C16284748780-11030e365-467e-111a-e063-dadaa90a10e2N3
63083-4003-22024-01-30C16284748780-11030e365-467e-111a-e063-dadaa90a10e2N3
63083-4003-22024-01-30C16284748780-11030e365-467e-111a-e063-dadaa90a10e2N3

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63083-4003-2Virus Nosode400359 mL in 1 BOTTLE, DROPPERLIQUID592

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63083-4003VIRUS NOSODE 4003 (VIRUS NOSODE) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS]1Current NDC, Legacy NDC, 1 package rows20220301_626d937d-45db-4ccf-a75b-e961e2a80852.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63083-4003-26308340030259 mL in 1 BOTTLE, DROPPER (63083-4003-2) 59 ml1985-08-150000-00-00NoNoCurrent